Malignant Pleural Mesothelioma with Concurrent Pleural Plaques Following Occupational Asbestos Exposure: A Case Report
Keywords:
malignant mesothelioma, pleural plaque, asbestos-related disease, occupational disease, asbestosAbstract
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm primarily associated with occupational asbestos exposure and typically manifests decades after initial contact. We report the case of a 73-year-old Thai male presented with non-productive cough, progressive dyspnea and left-sided pleuritic chest pain for 3 months. He underwent medical thoracoscopy with pleural biopsy and was diagnosed with malignant pleural mesothelioma with pulmonary metastases. The patient had a 39-year occupational history as an asbestos processing operator in a roof-tile factory and had ceased asbestos exposure for over 10 years before developing symptoms. Imaging demonstrated a pleural mass, loculated effusion, and multiple calcified pleural plaques, while histopathology and immunohistochemistry confirmed MPM. Despite chemotherapy, his condition deteriorated, leading to palliative care.
This case emphasizes the aggressive course of malignant pleural mesothelioma, the prolonged latency of asbestos-related disease, and illustrates that clinical manifestations can occur long after cessation of exposure. It highlights the urgent need for preventive policies, strict regulation of asbestos, and comprehensive occupational health strategies. Importantly, periodic health examinations and long-term surveillance of asbestos-exposed workers remain essential even after exposure cessation or retirement, to support early detection and strengthen preventive strategies.
References
Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 2007;45(3):379-87.
Milano MT, Zhang H. Malignant pleural mesothelioma: a population-based study of survival. J Thorac Oncol 2010;5:1841-8.
British Thoracic Society. BTS statement on malignant mesothelioma in the UK, 2007. Thorax 2007;62(Suppl 2):1–19.
International Agency for Research on Cancer. List of classifications by cancer sites with sufficient or limited evidence in humans [Internet]. 2016 [cited 2025 Aug 10]. Available from: https://shorturl.asia/KSPcO
World Health Organization. Elimination of asbestos-related diseases [Internet]. 2018 [cited 2025 Aug 10]. Available from: https://shorturl.asia/ZGfbl
Chen T, Sun XM, Wu L. High time for complete ban on asbestos use in developing countries. JAMA Oncol 2019;5(6):779-80.
Peacock C, Copley SJ, Hansell DM. Asbestos-related benign pleural disease. Clin Radiol 2000;55:422-32.
Wongvitvichot S, Jiamjarasrangsi W, Sriuranpong V. Occupational malignant mesothelioma in Thailand. J Health Sci Thail 2018;18(2):155–62.
Subhannachart P, Dumavibhat N, Siriruttanapruk S. Asbestos-related diseases in Thailand and review literature. J Med Assoc Thai 2012;95:71-6.
Occupational Safety and Health Administration. Occupational exposure to asbestos. 29 CFR 1910.1001. Washington, DC: U.S. Department of Labor; 2023.
Mott FE. Mesothelioma: a review. Ochsner J 2012;12(1):70-9.
Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health 2015;41(1):5–15.
Nishikawa K, Takahashi K, Karjalainen A, Wen CP, Furuya S, Hoshuyama T, et al. Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment. Environ Health Perspect 2008;116(12): 1675–80.
Surasak B, Pornchai S, Narongpon D, Chalermchai C, Wantanee P, Somkiat S, et al. Revision of National Health Assembly Resolution: Thailand’s Asbestos Ban Measures. Thai J Public Health Sci 2020;14(1):9-18.
Park EK, Takahashi K, Hoshuyama T, Cheng TJ, Delgermaa V, Le GV, et al. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect 2011;119(4):514–8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 สมาคมเวชศาสตร์ป้องกันแห่งประเทศไทย

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ลงพิมพ์ในวารสารเวชศาสตร์ป้องกันแห่งประเทศไทย ถือเป็นผลงานวิชาการ งานวิจัย วิเคราะห์ วิจารณ์ เป็นความเห็นส่วนตัวของผู้นิพนธ์ กองบรรณาธิการไม่จำเป็นต้องเห็นด้วยเสมอไปและผู้นิพนธ์จะต้องรับผิดชอบต่อบทความของตนเอง